Reported Standalone quarterly numbers for Astec Lifesciences are:
Net Sales at Rs 98.55 crore in September 2024 down 11.05% from Rs. 110.79 crore in September 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 38.57 crore in September 2024 down 186.88% from Rs. 13.45 crore in September 2023.
EBITDA stands negative at Rs. 17.75 crore in September 2024 down 618.62% from Rs. 2.47 crore in September 2023.
Astec Life shares closed at 1,060.90 on October 24, 2024 (NSE) and has given -14.70% returns over the last 6 months and -11.87% over the last 12 months.
Story continues below Advertisement
| Astec Lifesciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'24 | Jun'24 | Sep'23 | | Net Sales/Income from operations | 98.55 | 69.37 | 110.79 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 98.55 | 69.37 | 110.79 | | EXPENDITURE | | Consumption of Raw Materials | 66.38 | 33.71 | 72.38 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 13.85 | 47.88 | 3.64 | | Power & Fuel | -- | -- | -- | | Employees Cost | 14.93 | 16.23 | 17.25 | | Depreciation | 11.49 | 9.28 | 9.17 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 23.12 | 17.80 | 20.94 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -31.22 | -55.53 | -12.59 | | Other Income | 1.98 | 0.91 | 0.96 | | P/L Before Int., Excpt. Items & Tax | -29.24 | -54.62 | -11.64 | | Interest | 9.34 | 7.05 | 6.00 | | P/L Before Exceptional Items & Tax | -38.57 | -61.67 | -17.64 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -38.57 | -61.67 | -17.64 | | Tax | -- | -21.93 | -4.19 | | P/L After Tax from Ordinary Activities | -38.57 | -39.74 | -13.45 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -38.57 | -39.74 | -13.45 | | Equity Share Capital | 19.61 | 19.61 | 19.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -19.67 | -20.26 | -6.86 | | Diluted EPS | -19.67 | -20.26 | -6.86 | | EPS After Extra Ordinary | | Basic EPS | -19.67 | -20.26 | -6.86 | | Diluted EPS | -19.67 | -20.26 | -6.86 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
